RxSight (RXST) Retained Earnings (2021 - 2026)
RxSight (RXST) posted Retained Earnings of -$67000.0 for Q1 2026, down 100.01% on a QoQ basis from $936.6 million in Q4 2025, and down 100.01% year-over-year from $909.5 million in Q1 2025.
RxSight (RXST) Retained Earnings (2021 - 2026) Analysis & Trends
RxSight's Retained Earnings history runs 6 years deep, the most recent figure standing at -$67000.0 for Q1 2026.
- Quarterly Retained Earnings fell 100.01% year-over-year to -$67000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$67000.0 (down 100.01% YoY) and the FY2025 annual result came in at $936.6 million, up 564133.73% from the prior year.
- Retained Earnings was -$67000.0 for Q1 2026 at RxSight, down from $936.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at $936.6 million in Q4 2025 and bottomed at -$651.9 million in Q3 2025.
- A 5-year average of -$126.4 million and a median of -$513.6 million in 2022 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 17120033.33% — and 2023, when it soared 718700.0%.
- RxSight's Retained Earnings stood at $636.0 million in 2022, then plunged by 193.5% to -$594.6 million in 2023, then soared by 100.03% to $166000.0 in 2024, then soared by 564133.73% to $936.6 million in 2025, then tumbled by 100.01% to -$67000.0 in 2026.
- Business Quant data shows RXST's Retained Earnings at -$67000.0 in Q1 2026, $936.6 million in Q4 2025, and -$651.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -6.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -4.10 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 6.91 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 14.62 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.63 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -1.40 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 5.32 Bn |
| 10 | RxSight | 221.81 Mn | -196.39 Mn | 23.50 Mn | -67,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67,000.00 |
| Dec 31, 2025 | 936.63 Mn |
| Sep 30, 2025 | -651.89 Mn |
| Jun 30, 2025 | -642.07 Mn |
| Mar 31, 2025 | 909.55 Mn |
| Dec 31, 2024 | 166,000.00 |
| Sep 30, 2024 | -616.16 Mn |
| Jun 30, 2024 | -609.82 Mn |
| Mar 31, 2024 | -603.74 Mn |
| Dec 31, 2023 | -594.64 Mn |
| Sep 30, 2023 | -60,000.00 |
| Jun 30, 2023 | -573.05 Mn |
| Mar 31, 2023 | 704.23 Mn |
| Dec 31, 2022 | 636.00 Mn |
| Sep 30, 2022 | -530.42 Mn |
| Jun 30, 2022 | -513.60 Mn |
| Mar 31, 2022 | -98,000.00 |
| Dec 31, 2021 | 617.51 Mn |
| Sep 30, 2021 | 614.42 Mn |
| Jun 30, 2021 | -3,000.00 |